The decision to restart the ACTA negotiations makes it important to understand the nature and consequence of proposed agreement. Following a complaint about transparency, this note focuses on damages and injunctions.
From the European Parliament is a call for more transparency of ACTA documents. This is a report from Sina Amoor Pour of Sweden, posted to the A2K listserve:
March 2009 news stories on the denial of access to ACTA documents under FOIA on national security groundsSubmitted by James Love on 14. March 2009 - 2:36
The following are some of the stories on the denial of the ACTA FOIA request on national security grounds.
March 12, 2009
Obama Administration Rules Texts of New IPR Agreement are State Secrets
Huffington Post, James Love, March 12, 2009.
The negotiating text of ACTA and many other documents, including even the lists of participants in the negotiations, are secret. The White House claims the secrecy is required as a matter of national security. But that does not mean the documents are off limits to everyone outside of the government. Hundreds of advisors, many of them corporate lobbyists, are considered “cleared advisors.” They have access to the ACTA documents.
NGO views: World Health Organization (WHO) voice on issue of medicines in transit to developing countries?Submitted by thiru on 13. March 2009 - 3:51
On 18 February 2009, 16 civil society groups sent a letter to Director-General Dr. Chan on the matter of the Dutch seizures of generic medicines in-transit to developing countries. In the letter, Dr.
On January 31, 2009, KEI submitted a Freedom of Information Act (FOIA) request to USTR for copies of seven documents containing much of the negotiating text of the proposed Anti-Counterfeiting Trade Agreement (ACTA). Today the White House office the United States Trade Representative denied the request, claiming the documents are “information that is properly classified in the interest of national security pursuant to Executive Order 12958.”
One of the more aggressive PhRMA submissions to the USTR Special 301 list is the section on the Philippines. Excerpts, which are given below, illustrate the breath of PhRMA’s demands on the USTR.
In today’s Financial Times, Andrew Jack, Frances Williams and Michael Steen report on Dutch seizure of generic Abacavir in transit to Africa:
Dozens of HIV patients have been placed at risk after the Dutch authorities seized consignments of Indian-made medicines shipped via Schipol airport for distribution to clinics in Nigeria, a multilateral agency yesterday said.
On 3 March 2009, the following intervention was delivered by Ambassador Roberto Azevêdo, Permanent Representative of Brazil to the WTO and other economic organizations in Geneva.
Agenda item ‘M’ – OTHER BUSINESS – Public Health dimension of TRIPS Agreement
Statement by Brazil
On Tuesday, 20 May 2008, the United Arab Emirates, Nigeria, Ghana, Gambia and Tunisia introduced a draft resolution (A61/A/Conf. Paper No 1) on counterfeiting.
While counterfeiting medicines is an important public health problem, and as traditionally defined, is a criminal enterprise that should be subject to tough legal sanctions, the resolution is problematic.